Immunoglobulins, Intravenous
"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
| Descriptor ID |
D016756
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
|
| Concept/Terms |
Immunoglobulins, Intravenous- Immunoglobulins, Intravenous
- Intravenous IG
- Intravenous Antibodies
- IVIG
- Immune Globulin, Intravenous
- Intravenous Immune Globulin
- Antibodies, Intravenous
- Intravenous Immunoglobulins
- IV Immunoglobulins
- Immunoglobulins, IV
Intravenous Immunoglobulins, Human- Intravenous Immunoglobulins, Human
- Human Intravenous Immunoglobulins
- Immunoglobulins, Human Intravenous
- Immune Globulin Intravenous (Human)
- Immunoglobulins, Intravenous, Human
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".
This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 1 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 3 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 6 | 4 | 10 |
| 2020 | 1 | 4 | 5 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 2 | 3 |
| 2025 | 2 | 2 | 4 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
Parent perceptions of various treatment approaches for PANS and PANDAS. J Affect Disord. 2025 Jan 15; 369:1215-1222.
-
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 02; 30(2):217-227.
-
Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies. Ultrasound Obstet Gynecol. 2023 07; 62(1):148-151.
-
Viral Coinfections in Kawasaki Disease: A Meta-analysis. Hosp Pediatr. 2023 06 01; 13(6):e153-e169.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022 04; 74(4):586-596.
-
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care Res (Hoboken). 2022 04; 74(4):538-548.
-
Intravenous immunoglobulin in heart transplant recipients with mild to moderate hypogammaglobulinemia and infection. Clin Transplant. 2022 04; 36(4):e14571.
-
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021 12; 5(12):852-861.
-
Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplant Proc. 2021 Jul-Aug; 53(6):1865-1871.
-
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.